80f23ea7-52db-4f12-ad6f-50989b85f382

top of page

Interrogate Tumor-Immune Interactions in AML Patients Receiving Immune Checkpoint Inhibitors

31 May 2022 at 4:00:00 pm

Last Name

First Name

Contact Number

Email ID

Institute Name

Department Name

Proceed

Thank you! You will now be redirected to the registration page.

Designation

bottom of page